Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 13 of the 24 sources its claims cite were checked for support.

Invasive candidiasis species distribution and trends, United States, 2009-2017

Open access

Abstract

BACKGROUND: Invasive candidiasis (IC) is a growing concern among US healthcare facilities. A large-scale study evaluating incidence and trends of IC in the United States by species and body site is needed to understand the distribution of infection. METHODS: An electronic medical record database was used to calculate incidence and trends of IC in the United States by species and infection site from 2009 through 2017. Hospital incidence was calculated using total unique inpatient hospitalizations in hospitals reporting at least 1 Candida case as the denominator. IC incidence trends were assessed using generalized estimating equations with exchangeable correlation structure to fit Poisson regression models, controlling for changes in hospital characteristics and case mix over time. RESULTS: Candida albicans remains the leading cause of IC in the United States, followed by Candida glabrata. The overall incidence of IC was 90/100 000 patients, which did not change significantly over time. There were no changes in incidence among C. albicans, C. glabrata, C. parapsilosis, or C. tropicalis; the incidence of other Candida spp. as a whole increased 7.2% annually. While there was no change in candidemia 2009-2017, abdominal and nonabdominal sterile site IC increased significantly. CONCLUSIONS: Nonbloodstream IC is increasing in the United States. Understanding the epidemiology of IC should facilitate improved management of infected patients.

Overview

CoChat Summary

TL;DR

Invasive candidiasis (IC) incidence in a large US electronic health record database was 90 per 100,000 hospitalizations from 2009–2017 and did not change significantly overall. Although candidemia remained stable, nonbloodstream IC—especially abdominal and nonabdominal sterile site infections—increased significantly.

Key findings

  • Among 18,728 invasive Candida isolates from 17,103 encounters, C. albicans was most common (48%, n = 8989), followed by C. glabrata (24%, n = 4432), C. parapsilosis (11%, n = 1969), C. tropicalis (7%, n = 1295), and other Candida spp. (6%, n = 1189).
  • Overall IC incidence was 90/100,000 hospitalizations, with no significant annual change (APC, 1.3%; 95% CI, −1.5% to 4.1%); incidence increased only for other Candida spp. as a group (APC, 7.2%; 95% CI, 2.8%–12%).
  • Candidemia incidence did not change significantly overall, but decreased for C. albicans (APC, −3.2%; 95% CI, −6.1% to −.1%); abdominal IC increased 5.5% annually (95% CI, 1.8%–9.3%) and nonabdominal sterile site IC increased 10% annually (95% CI, 5.0%–16%).
  • Unadjusted mortality was higher for C. glabrata than C. albicans (27% vs 22%, P < .001) and lower for C. parapsilosis than C. albicans (17% vs 21%, P < .001); mortality was 28% for candidemia, 16% for abdominal IC, and 10% for nonabdominal sterile site IC.

Methods

  • Retrospective analysis of the Cerner HealthFacts electronic medical record database, including linked records for more than 63 million US patients; the study extracted hospital encounters from 2009–2017 with Candida isolated from blood, sterile abdominal, or other nonabdominal sterile sites.
  • The analytic population included 19,381,763 unique inpatient encounters at 203 hospitals reporting at least 1 Candida case; 18,728 Candida isolates from 17,103 encounters and 16,334 patients were identified, with only the first encounter counted if the same species was isolated within 30 days.
  • Hospital incidence used total unique inpatient hospitalizations in hospitals reporting at least 1 Candida case as the denominator; trends were assessed with generalized estimating equations using an exchangeable correlation structure to fit Poisson regression models, controlling for hospital characteristics and case mix over time.

Limitations

  • The authors state that sterile site infections and candidemic patients with deep-seated infections may be missed because of limitations in current detection methods, and that species identification systems varied across more than 200 hospitals without centralized confirmatory testing.
  • The authors state that only one-third of Candida isolates were tested for in vitro antifungal resistance, so resistance could not be assessed directly; hospitals also did not necessarily participate every year, with only 55 of 203 hospitals continuously reporting Candida throughout the study period.
  • The authors state that participation was elective and that 93 hospitals reporting microbiology but no Candida cases were primarily small, nonteaching facilities largely in the West, limiting generalizability; they also note possible incomplete 2017 reporting, though trends did not change when that year was excluded.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiaa502

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 0 Not valid · 2 Not checked · 38 Own results and interpretations

27 more claims

Create a free account to see all 51 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 35 references

Cited by

See all 114

Metadata

Authors
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J.
Affiliations
  • National Institutes of Health (US)
  • Emory University (US)
Corresponding author
Ricotta, Emily E
Venue
The Journal of Infectious Diseases
Published
2020-08-15
Volume
223
Issue
7
Pages
1295-1302
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W3049534229
Cited by
114
References
35
Citations by year
2026: 16 · 2025: 20 · 2024: 19 · 2023: 17 · 2022: 18 · 2021: 21 · 2020: 3
FWCI
1.93
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion, public-domain)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health Clinical Center
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords
invasive candidiasis, Candida species distribution, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, candidemia, incidence trends, hospitalization, United States
MeSH terms
Antifungal Agents, Candida, Humans, Microbial Sensitivity Tests, United States, Incidence, Candidiasis, Invasive, Candidemia, Introduced Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Invasive candidiasis species distribution and trends, United States, 2009-2017. https://app.cochat.ai/papers/10.1093/infdis/jiaa502
The paper
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021). Invasive candidiasis species distribution and trends, United States, 2009-2017. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaa502

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.